These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 17474449)

  • 1. [Clinical trials to improve the results of chemotherapy for acute myeloid leukemia].
    Ohtake S
    Nihon Rinsho; 2007 Jan; 65 Suppl 1():469-73. PubMed ID: 17474449
    [No Abstract]   [Full Text] [Related]  

  • 2. On the road to new drugs in acute myeloid leukemia.
    Löwenberg B
    J Clin Oncol; 2007 Jan; 25(1):1-2. PubMed ID: 17146103
    [No Abstract]   [Full Text] [Related]  

  • 3. Induction therapy and outcome in acute myeloid leukemia.
    Mehta J
    Cancer; 2011 May; 117(10):2236-7; author reply 2237. PubMed ID: 21523737
    [No Abstract]   [Full Text] [Related]  

  • 4. [Results of treating acute myeloid leukemia resistant to conventional chemotherapy with moderately large doses of cytarabine and etoposide].
    Robak T; Krykowski E; Matusewicz W; Brodowski L; Hołub A; Drzewoski J
    Pol Tyg Lek; 1988 Nov; 43(47):1508-11. PubMed ID: 3075284
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of elderly patients with acute myeloid leukemia].
    Löwenberg B
    Ned Tijdschr Geneeskd; 1997 Nov; 141(45):2157-9. PubMed ID: 9550795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prognostic significance of age and karyotype in the treatment of acute myeloid leukemia: results at our center].
    Nahajevszky S; Kapás B; Adám E; Lovas N; Halm G; Gopcsa L; Tamáska J; Poros A
    Orv Hetil; 2004 Jan; 145(4):167-72. PubMed ID: 14978882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early discharge from hospital after consolidation chemotherapy in acute myeloid leukemia in remission: febrile neutropenic episodes and their outcome in a resource poor setting.
    Naithani R; Kumar R; Mahapatra M; Agrawal N; Mishra P
    Haematologica; 2008 Sep; 93(9):1416-8. PubMed ID: 18603560
    [No Abstract]   [Full Text] [Related]  

  • 8. Current chemotherapeutic treatment approaches to the management of previously untreated adults with de novo acute myelogenous leukemia.
    Mayer RJ
    Semin Oncol; 1987 Dec; 14(4):384-96. PubMed ID: 3321443
    [No Abstract]   [Full Text] [Related]  

  • 9. High dose cytarabine in acute myelogenous leukemia.
    Zittoun R
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():38-42. PubMed ID: 2653516
    [No Abstract]   [Full Text] [Related]  

  • 10. Results of syngeneic hematopoietic stem cell transplantation for acute leukemia: risk factors for outcomes of adults transplanted in first complete remission.
    Fouillard L; Labopin M; Gratwohl A; Gluckman E; Frassoni F; Beelen DW; Willemze R; Montserrat E; Blaise D; Atienza AI; Sierra J; Santos M; Gorin NC; Rocha V;
    Haematologica; 2008 Jun; 93(6):834-41. PubMed ID: 18469352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of response to reinduction chemotherapy for patients with acute myeloid leukemia who do not achieve complete remission with frontline induction chemotherapy.
    Brandwein JM; Gupta V; Schuh AC; Schimmer AD; Yee K; Xu W; Messner HA; Lipton JH; Minden MD
    Am J Hematol; 2008 Jan; 83(1):54-8. PubMed ID: 17696207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress toward predictive models for the outcome of treatment for acute nonlymphocytic leukemia.
    Preisler HD; Raza A
    Oncology (Williston Park); 1987 May; 1(3):49-59, 62. PubMed ID: 3079480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Quality of life in patients with acute myeloid leukemia].
    Schumacher A
    Med Klin (Munich); 1994 Aug; 89(8):410-5. PubMed ID: 7968873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective cytomegalovirus monitoring during first-line chemotherapy in patients with acute myeloid leukemia.
    Capria S; Gentile G; Capobianchi A; Cardarelli L; Gianfelici V; Trisolini SM; Foà R; Martino P; Meloni G
    J Med Virol; 2010 Jul; 82(7):1201-7. PubMed ID: 20513085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Current status of complete remission rate of acute leukemia in Shanghai].
    Shanghai Leukemia Cooperative Group Shanghai 200040 China
    Zhonghua Xue Ye Xue Za Zhi; 2000 Jan; 21(1):17-9. PubMed ID: 11876954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. More on the treatment of relapsed acute myeloid leukemia.
    Capizzi RL
    Oncology (Williston Park); 1989 Oct; 3(10):72-4. PubMed ID: 2701211
    [No Abstract]   [Full Text] [Related]  

  • 17. [Remission induction treatment in adults with acute myeloid leukemia. 8-year experience with 2 successive protocols].
    del Potro E; Díaz Mediavilla J; Martínez R; Alvarez A; Krsnik I; Guerra JL; Llorente L; López JC; Díaz Morfa M; Villegas A
    Med Clin (Barc); 1989 Apr; 92(16):601-4. PubMed ID: 2747321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remission induction therapy for adults with acute myelogenous leukemia: towards the ICE age?
    Bassan R; Barbui T
    Haematologica; 1995; 80(1):82-90. PubMed ID: 7758997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of acute myeloid leukemia in a special hematology unit].
    Douer D; Ben-Bassat I; Singer A; Ramot B
    Harefuah; 1990 Jan; 118(2):57-61. PubMed ID: 2312003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel strategies for relapsed and refractory acute myeloid leukemia.
    Mato AR; Morgans A; Luger SM
    Curr Opin Hematol; 2008 Mar; 15(2):108-14. PubMed ID: 18300756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.